| Business Summary | | Gish
Biomedical,
Inc.
was
founded
to
design,
produce
and
market
specialty
surgical
devices
for
various
applications
within
the
medical
community.
The
Company
operates
in
one
industry
segment,
the
manufacture
of
medical
devices,
which
are
marketed
domestically
and
internationally.
All
of
Gish's
products
are
single-use
disposable
products
or
have
a
disposable
component.
The
Company's
primary
markets
include
products
for
use
in
cardiac
surgery,
myocardial
management,
infusion
therapy
and
post-operative
blood
salvage.
Current
products
offered
by
the
Company
include
custom
cardiovascular
tubing
systems,
arterial
filters,
cardiometry
reservoirs,
Vision
oxygenators,
venous
reservoirs
(including
the
CAPVRF45),
cardioplegia
delivery
systems,
oxygen
saturation
monitors,
critical
care
central
venous
access
catheters
and
ports,
and
the
Orthofuser. | More
from
Market Guide: Expanded
Business Description |
| Financial Summary | | Gish
Biomedical
designs,
produces,
and
markets
specialty
surgical
devices
for
use
in
cardiac
surgery,
myocardial
management,
infusion
therapy,
and
post
operative
blood
salvage.
For
the
nine
months
ended
3/31/01,
revenues
fell
1%
to
$13.3
million.
Net
loss
fell
35%
to
$1.6
million.
Revenues
reflect
lower
sales
volumes
across
all
product
lines
except
for
oxygenator.
Lower
loss
reflects
the
absence
of
a
$294
thousand
severance
and
related
cost. | More
from
Market Guide: Significant
Developments |
| | |
| Position | John Galuchie, Jr., 47 | Chairman | Kelly Scott, 44 | Pres,
CEO, Director |
| More
from
Market Guide on Officers & Directors: Expanded
List, Bios,
Compensation,
Options
|
|